INmune Bio Inc (INMB) Q3 2026 Earnings Call Highlights: UK Approval Path for Ebstracell Narrows ...
INmune Bio Inc (INMB) targets a February 2027 UK marketing application and mid-2027 approval for Ebstracell while funding operations only through Q3 2027. Related Stocks: INMB ,